Get the Stockscreener App
93.94
1.00%
1.288
Zimmer Biomet Holdings Inc stock is traded at $93.94, with a volume of 35,959.
It is up +1.00% in the last 24 hours and down -0.74% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$92.65
Open:
$91.85
24h Volume:
35,959
Relative Volume:
0.02
Market Cap:
$18.62B
Revenue:
$7.83B
Net Income/Loss:
$825.20M
P/E Ratio:
22.87
EPS:
4.1067
Net Cash Flow:
$1.05B
1W Performance:
+3.07%
1M Performance:
-0.74%
6M Performance:
-0.10%
1Y Performance:
-9.64%
1-Day Range:
$91.77
$93.96
1-Week Range:
$89.50
$93.52
52-Week Range:
$85.33
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
93.96 | 18.36B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
128.41 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.54 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.37 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.75 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.69 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
Raymond James Downgrades Zimmer Biomet to Market Perform From Outperform - marketscreener.com
Evercore ISI Group Upgrades Zimmer Biomet Holdings (ZBH) Rating - GuruFocus
Who Owns Zimmer Biomet? Top Shareholders and Recent Insider Trades - TIKR.com
What analysts say about Zimmer Biomet Holdings Inc stockSmall Cap Stock Opportunities & High Profit Trading Plans - earlytimes.in
Pacer Advisors Inc. Cuts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Calamos Advisors LLC Has $4.66 Million Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet lawsuit against Deloitte Consulting continues to move through New York court - The Journal Gazette
Cervical Total Disc Replacement Device Market 2025 Forecast: - openPR.com
Earnings Update: Will Zimmer Biomet Holdings Inc stock outperform value stocksJuly 2025 Momentum & Daily Technical Stock Forecast Reports - moha.gov.vn
Zimmer Biomet Holdings, Inc.: - marketscreener.com
Boston Trust Walden Corp Has $65.02 Million Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Collagen Meniscus Implant Market Forecast: Unveiling - openPR.com
Kempner Capital Management Inc. Sells 27,095 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Ex-Dividend Reminder: John Wiley & Sons, Xcel Energy and Zimmer Biomet Holdings - Nasdaq
Zimmer Biomet Holdings, Inc. $ZBH is QSM Asset Management Ltd's Largest Position - MarketBeat
Voya Investment Management LLC Has $5.36 Million Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zacks Research Predicts Weaker Earnings for Zimmer Biomet - MarketBeat
Is Zimmer Biomet Holdings Inc. stock a buy in volatile marketsGlobal Market Influence & Capital Allocation Recommendations - Bollywood Helpline
Zimmer Biomet: Execution Remains The Sticking Point (NYSE:ZBH) - Seeking Alpha
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
EBITDA per share of Zimmer Biomet Holdings, Inc. – FWB:ZIM - TradingView — Track All Markets
Wedge Capital Management L L P NC Sells 17,263 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
Douglas Lane & Associates LLC Purchases 29,011 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Rating of "Hold" by Brokerages - MarketBeat
Benson Investment Management Company Inc. Acquires New Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Have Endured a 36% Loss From Investing in the Stock Five Years Ago - 富途牛牛
Is Zimmer Biomet Holdings Inc. stock overvalued by current metricsQuarterly Market Summary & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
Why Zimmer Biomet Holdings Inc. (ZIM) stock is a strong analyst pickMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Yahoo Finance
How Investors Are Reacting To Zimmer Biomet (ZBH) Dividend Move And OneStep Digital Recovery Partnership - simplywall.st
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Will Zimmer Biomet Holdings Inc. stock benefit from sector rotationMarket Growth Report & Consistent Growth Stock Picks - Улправда
Bactiguard Announces Updated Trauma License Agreement with Zimmer Biomet - marketscreener.com
How Zimmer Biomet Holdings Inc. stock reacts to job market data2025 Major Catalysts & Reliable Price Breakout Alerts - DonanımHaber
How Zimmer Biomet Holdings Inc. (ZIM) stock valuation compares with sectorJuly 2025 Update & Expert-Curated Trade Recommendations - DonanımHaber
Bactiguard Updates Licensing Agreement with Zimmer Biomet - marketscreener.com
Bactiguard announces updated trauma license agreement with Zimmer Biomet - marketscreener.com
Will Zimmer Biomet Holdings Inc. stock outperform value stocksPortfolio Performance Report & Weekly Return Optimization Plans - DonanımHaber
What risks investors should watch in Zimmer Biomet Holdings Inc. stock - DonanımHaber
How Zimmer Biomet Holdings Inc. stock performs during Fed tightening cyclesQuarterly Trade Report & Community Consensus Trade Signals - DonanımHaber
What momentum indicators show for Zimmer Biomet Holdings Inc. stockJuly 2025 Closing Moves & Advanced Technical Signal Analysis - DonanımHaber
Why retail investors pile into Zimmer Biomet Holdings Inc. stockJuly 2025 Levels & Daily Entry Point Trade Alerts - DonanımHaber
Fund Flows: Why Zimmer Biomet Holdings Inc. (ZIM) stock is a strong analyst pick2025 EndofYear Setup & Fast Exit and Entry Trade Guides - Улправда
How Zimmer Biomet Holdings Inc. stock valuations compare to rivalsQuarterly Market Review & Fast Entry High Yield Stock Tips - DonanımHaber
Why Zimmer Biomet Holdings Inc. stock appeals to dividend seekers2025 Risk Factors & Real-Time Volume Surge Alerts - Улправда
How Investors May Respond To Zimmer Biomet (ZBH) Pairing a Q4 Dividend With OneStep Mobility Analytics - Yahoo Finance
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Risk Recap: Will Zimmer Biomet Holdings Inc. stock benefit from sector rotationJuly 2025 Trade Ideas & High Accuracy Swing Entry Alerts - Улправда
Zimmer Biomet Holdings, Inc. $ZBH Stock Holdings Boosted by Oak Thistle LLC - MarketBeat
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zimmer Biomet Holdings Inc Stock (ZBH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Upadhyay Suketu | Exec VP, CFO |
Nov 10 '25 |
Option Exercise |
0.00 |
10,632 |
0 |
59,485 |
| Yi Sang | Group President, Asia Pacific |
Sep 11 '25 |
Sale |
103.58 |
1,200 |
124,302 |
18,584 |
0.45%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):